Metabolic syndrome (MetS), sometimes called “insulin resistance syndrome” or “syndrome X”, refers to a cluster of interrelated risk factors for cardiovascular disease and type 2 diabetes, specifically enlarged waist circumference, elevated triglycerides, high blood pressure, low high-density lipoprotein cholesterol, and impaired fasting glucose.[1] It’s estimated that the global prevalence of MetS is about 25%,[2] while in the United States it’s nearly 35%.[3]
References
- ^Supreeya Swarup, Amandeep Goyal, Yulia Grigorova, Roman ZeltserMetabolic Syndrome
- ^Saklayen MGThe Global Epidemic of the Metabolic SyndromeCurr Hypertens Rep.(2018 Feb 26)
- ^Hirode G, Wong RJTrends in the Prevalence of Metabolic Syndrome in the United States, 2011-2016.JAMA.(2020-06-23)